Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Health Care Poor Underserved ; 25(1 Suppl): 46-62, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24583487

RESUMO

Genetic testing for inheritable cancer syndromes is becoming a critical part of preventive health services. The Patient Protection and Affordable Care Act (PPACA) Essential Health Benefits package addresses breast cancer susceptibility-gene testing for women who are unaffected by cancer. The absence of provisions for 1) men, 2) cancer patients, 3) other inheritable cancer syndromes, and 4) risk-reducing interventions are limitations of PPACA. We discuss provisions and limitations of PPACA pertaining to genetic testing and effects on high-risk populations, in particular minorities. The PPACA is the beginning of an ongoing process of incorporating genetic testing in the armamentarium of cancer prevention. Future efforts should focus on ensuring equitable access to genetic testing as a preventive service under PPACA to high-risk populations other than women. Consideration should also be given to provisions for risk-reducing interventions, especially in underserved minority populations, who are known to underutilize genetic testing and may have limited financial resources for medical intervention.


Assuntos
Testes Genéticos/legislação & jurisprudência , Síndromes Neoplásicas Hereditárias/diagnóstico , Síndromes Neoplásicas Hereditárias/prevenção & controle , Patient Protection and Affordable Care Act , Populações Vulneráveis/etnologia , Feminino , Humanos , Masculino , Medição de Risco/métodos
2.
J Natl Med Assoc ; 100(5): 480-8, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18507200

RESUMO

BACKGROUND: This study presents black-white breast cancer statistics, tumor histology and receptor status, and treatment patterns for all ages and by age groups (< 40, 40-49, and > or = 50). METHODS: The study used data from the National Cancer Institute (NCI) Surveillance, Epidemiology and End Results (SEER) program for the time period 1995-2004. Age-adjusted incidence, mortality, relative survival rates, tumor grade, histology and receptor status, and treatment patterns for invasive breast cancer were calculated for nine SEER cancer registries for 1995-2004. RESULTS: Invasive breast cancer age-adjusted incidence for black women age < 40 was significantly higher than those for white women (rate ratio = 1.16, 95% confidence interval: 1.10-1.23). Age-adjusted mortality rate for black women age < 40 was twice that for white women. Compared to white women, black women were significantly more likely to be diagnosed with regional or distant disease, have lower relative five-year survival rate and have higher likelihood of being diagnosed with tumors with poorer prognosis. Black women were less likely to receive breast cancer surgery as part of the treatment plan. CONCLUSIONS: Race/ethnic disparities in invasive breast cancer epidemiology, prognostic indicators and treatment patterns exist between black and white women. The study findings support the need for innovative research, especially on the multifaceted determinants of the differential epidemiology of breast cancer. Equally important, there is a need for evidence-guided equal delivery of quality care to eliminate breast cancer disparities among black women.


Assuntos
Negro ou Afro-Americano , Neoplasias da Mama/epidemiologia , Disparidades nos Níveis de Saúde , Saúde das Minorias , População Branca , Adulto , Neoplasias da Mama/mortalidade , Neoplasias da Mama/patologia , Estudos Epidemiológicos , Feminino , Humanos , Incidência , Pessoa de Meia-Idade , Prognóstico , Sistema de Registros , Fatores de Risco , Programa de SEER , Estados Unidos/epidemiologia
3.
Cancer ; 107(8 Suppl): 2061-70, 2006 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-16944470

RESUMO

The unequal burden of cancer in minority and underserved communities nationally and in Maryland is a compelling crisis. The Maryland Special Populations Cancer Research Network (MSPN) developed an infrastructure covering Maryland's 23 jurisdictions and Baltimore City through formal partnerships between the University of Maryland School of Medicine, University of Maryland Statewide Health Network, University of Maryland Eastern Shore, and community partners in Baltimore City, rural Eastern Shore, rural Western Maryland, rural Southern Maryland, and Piscataway Conoy Tribe and statewide American Indians. Guided by the community-based participatory framework, the MSPN undertook a comprehensive assessment (of needs, strengths, and resources available) that laid the foundation for programmatic efforts in community-initiated cancer awareness and education, research, and training. The MSPN infrastructure was used to implement successful and innovative community-based cancer education interventions and technological solutions; conduct education and promotion of clinical trials, cancer health disparities research, and minority faculty cancer research career development; and leverage additional resources for sustainability. MSPN engaged in informed advocacy among decision- and policymakers at state and national levels, and its community-based clinical trials program was recognized by the U.S. Department of Health and Human Services as a Best Practice Award. The solutions to reduce and eliminate cancer health disparities are complex and require comprehensive and focused multidisciplinary cancer health disparities research, training, and education strategies implemented through robust community-academic partnerships. Cancer 2006. (c) American Cancer Society.


Assuntos
Redes Comunitárias/organização & administração , Educação em Saúde , Acessibilidade aos Serviços de Saúde , Área Carente de Assistência Médica , Grupos Minoritários , Qualidade da Assistência à Saúde , Pesquisa Biomédica , Humanos , Relações Interinstitucionais , Maryland
4.
J Health Care Poor Underserved ; 16(2): 192-206, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15937382

RESUMO

Cancer in Maryland is a serious health concern for minority and underserved populations in rural and urban areas. This report describes the National Cancer Institute (NCI) supported Maryland Special Populations Cancer Network (MSPN), a community-academic partnership. The MSPN's priority populations include African Americans, Native Americans, and other medically underserved residents of rural and urban areas. The MSPN has established a community infrastructure through formal collaborations with several community partners located in Baltimore City, the rural Eastern Shore, and Southern and Western Maryland, and among the Piscataway Conoy Tribe and the other 27 Native American Tribes in Maryland. Key partners also include the University of Maryland Eastern Shore and the University of Maryland Statewide Health Network. The MSPN has implemented innovative and successful programs in cancer health disparities research, outreach, and training; clinical trials education, health disparities policy, and resource leveraging. The MSPN addresses the goal of the NCI and the Department of Health and Human Services (DHHS) to reduce and eventually eliminate cancer health disparities. Community-academic partnerships are the foundation of this successful network.


Assuntos
Grupos Minoritários , Neoplasias/etnologia , Neoplasias/terapia , Programas Médicos Regionais/organização & administração , Telemedicina , Populações Vulneráveis , Negro ou Afro-Americano , Relações Comunidade-Instituição , Acessibilidade aos Serviços de Saúde , Hispânico ou Latino , Humanos , Indígenas Norte-Americanos , Maryland , Modelos Organizacionais , National Institutes of Health (U.S.) , Neoplasias/epidemiologia , Serviços de Saúde Rural/organização & administração , Fatores Socioeconômicos , Estados Unidos , Universidades , Serviços Urbanos de Saúde/organização & administração
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA